Pharmacological inhibition of glutamate dehydrogenase 1 (GLUD1) improves functional recovery of neuromuscular junctions and muscle function in Duchenne muscular dystrophy.

Journal:
American Journal of Pathology
Published:
DOI:
10.1016/j.ajpath.2025.05.003
Affiliations:
15
Authors:
15
Go to article
Institutions Authors Share
VIB-KU Leuven Center for Cancer Biology, Belgium
7.000000
 0.47
Catholic University of Leuven (KU Leuven), Belgium
1.833333
 0.12
Institut Mondor de Recherche Biomédicale (IMRB), France
1.833333
 0.12
VIB-KU Leuven Center for Brain and Disease Research, Belgium
1.500000
 0.10
Sir Run Run Shaw Hospital (SRRSH), Zhejiang University School of Medicine, China
1.000000
 0.07
University of Minho (UM), Portugal
0.500000
 0.03
University of Turin (UNITO), Italy
0.500000
 0.03
CHU Henri-Mondor, France
0.500000
 0.03
Barretos Cancer Hospital, Brazil
0.333333
 0.02
Interested in Medical Biotechnology?